TG THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 95638000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2017-03-31) |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:09.723465+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0371282c-b90d-43d5-a32c-bc24065ad447
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001654954-18-005046Retrieved: 2026-08-19T09:42:09.723465+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/cash-and-equivalents/2017-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0371282c-b90d-43d5-a32c-bc24065ad447
History
- supersedes {"amount": 95637572, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001654954-17-004345)